2022
DOI: 10.51253/pafmj.v72i1.4255
|View full text |Cite
|
Sign up to set email alerts
|

Association of Abnormal Coagulation Tests in Dengue Fever with Clinical Outcomes of The Patients

Abstract: Objective: To assess the coagulation test abnormalities (prothrombin time, activated partial thromboplastin time and fibrin degradation products) in dengue fever patients and its impact on clinical outcomes of the patient. Study Design: Cross-sectional study. Place and Duration of Study: Hematology Department, Pakistan Naval Ship Shifa Hospital, Karachi Pakistan, from Aug 2016 to Feb 2017. Methodology: A total of 135, serologically proven positive dengue-infected IgM cases, based on enzyme-li… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 15 publications
1
1
0
Order By: Relevance
“…Increased PT and aPTT levels (Table 3 ) are associated with the severity of dengue infection due to a disruption in the coagulation cascade. Elevation of both PT and aPTT was statistically significant in DHF ( p 0.001) compared to DF, which is consistent with previous research [ 37 , 38 ]. Hemorrhagic manifestations, shock and plasma leakage is due to the decreased levels of circulating protein C, S, antithrombin III and elevated levels of tissue factor, thrombomodulin.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Increased PT and aPTT levels (Table 3 ) are associated with the severity of dengue infection due to a disruption in the coagulation cascade. Elevation of both PT and aPTT was statistically significant in DHF ( p 0.001) compared to DF, which is consistent with previous research [ 37 , 38 ]. Hemorrhagic manifestations, shock and plasma leakage is due to the decreased levels of circulating protein C, S, antithrombin III and elevated levels of tissue factor, thrombomodulin.…”
Section: Discussionsupporting
confidence: 92%
“…Hemorrhagic manifestations, shock and plasma leakage is due to the decreased levels of circulating protein C, S, antithrombin III and elevated levels of tissue factor, thrombomodulin. Similarly, reduction in coagulation such as II, V, VII, VIII, IX, X, antithrombin, and alpha-2 antiplasmin factors was reported in DHF [ 22 , 35 , 38 ].…”
Section: Discussionmentioning
confidence: 76%